Skip to main content

Table 1 Baseline clinical characteristics of renal amyloidosis patients

From: Precise diagnosis and typing of early-stage renal immunoglobulin-derived amyloidosis by label-free quantification of parallel reaction monitoring-based targeted proteomics

Clinical Characteristics

All Patients (n = 46)

Representative AL/AH/AHL Renal Amyloidosis (n = 36)

Early-Stage Renal Amyloidosis (n = 10)

Age (year)

59.5(52.25–65.75)

60(52.75–66)

55(51–63.25)

Sex (male/ female)

31/15

27/9

4/6

Serum creatinine (mg/dl)

0.85(0.71–1.37)

0.88(0.75–1.52)

0.74(0.64–0.85)

Serum albumin (g/l)

25.95(22.63–28.60)

24.45(21.70–28.60)

28.25(26.88–29.23)

24-h urine protein

4.52(2.73–6.36)

5.26(3.85–7.98)

2.15(1.52–3.16)

Peripheral edema

40

31

9

Full nephrotic syndrome

32

29

3

  1. Data are expressed as median (interquartile range) or n. AL/AH/AHL, light chain/heavy chain/heavy and light chain amyloidosis